In total, 19 candidate genes (ACSS1, AK5, ALCAM, CHRD, CLDN1, CLDN16, GALNT10, HERC5, LAMB1, NFE2L3, OSTF1, PGM2, PODXL, PRKD3, SLC4A8, THBS1, CPT1A, ATP1B1, ABCB1) were confirmed according to our previously mentioned criteria (Figure 1A); among them, CPT1A, ATP1B1, ABCB1 were considered as PRGs in ovarian cancer. The gene discussed is CLDN16; the disease is ovarian carcinoma.